Autolus Therapeutics (AUTL) Earnings Date, Estimates & Call Transcripts → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free AUTL Stock Alerts $4.39 +0.32 (+7.86%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (Mar. 14) -$0.44 Missed By -$0.18 Consensus EPS (Mar. 14) -$0.26 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAUTL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AUTL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. Autolus Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.30)($0.30)($0.30)Q2 20241($0.29)($0.29)($0.29)Q3 20241($0.28)($0.28)($0.28)Q4 20241($0.26)($0.26)($0.26)FY 20244($1.13)($1.13)($1.13)AUTL Earnings Date and InformationAutolus Therapeutics last issued its quarterly earnings results on March 14th, 2024. The reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.18. Autolus Therapeutics has generated ($1.20) earnings per share over the last year (($1.20) diluted earnings per share). Earnings for Autolus Therapeutics are expected to grow in the coming year, from ($0.71) to ($0.57) per share. Autolus Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Autolus Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024Estimated)------- 3/14/2024Q4 2023($0.26)($0.44)($0.18)($0.44)--11/2/2023Q3 2023($0.24)($0.26)($0.02)($0.26)$2.00 million$0.41 million8/3/2023Q2 2023($0.22)($0.26)($0.04)($0.26)--5/4/2023Q1 2023($0.28)($0.23)+$0.05($0.23)$1.09 million$1.29 million3/7/2023Q4 2022($0.31)($0.23)+$0.08($0.23)$4.50 million$3.83 million11/3/2022Q3 2022($0.46)($0.47)($0.01)($0.47)$0.30 million$2.37 millionShocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy.8/4/2022Q2 2022($0.42)($0.46)($0.04)($0.46)-- 5/5/2022Q1 2022($0.51)($0.41)+$0.10($0.41)$0.26 million$0.17 million 3/10/2022Q4 2021($0.49)($0.51)($0.02)($0.51)$0.27 million$0.18 million 11/2/2021Q3 2021($0.51)($0.47)+$0.04($0.47)$0.25 million$0.24 million 8/5/2021Q2 2021($0.50)($0.47)+$0.03($0.47)$0.31 million$1.65 million Autolus Therapeutics Earnings - Frequently Asked Questions When is Autolus Therapeutics's earnings date? Autolus Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on AUTL's earnings history. Did Autolus Therapeutics beat their earnings estimates last quarter? In the previous quarter, Autolus Therapeutics (NASDAQ:AUTL) missed the analysts' consensus estimate of ($0.26) by $0.18 with a reported earnings per share (EPS) of ($0.44). Learn more on analysts' earnings estimate vs. AUTL's actual earnings. How much revenue does Autolus Therapeutics generate each year? Autolus Therapeutics (NASDAQ:AUTL) has a recorded annual revenue of $1.70 million. How much profit does Autolus Therapeutics generate each year? Autolus Therapeutics (NASDAQ:AUTL) has a recorded net income of -$208.38 million. AUTL has generated -$1.20 earnings per share over the last four quarters. What is Autolus Therapeutics's EPS forecast for next year? Autolus Therapeutics's earnings are expected to grow from ($0.71) per share to ($0.57) per share in the next year. More Earnings Resources from MarketBeat Related Companies: BioCryst Pharmaceuticals Earnings Results Scholar Rock Earnings Results Cullinan Oncology Earnings Results Immatics Earnings Results ProKidney Earnings Results Relay Therapeutics Earnings Results Mesoblast Earnings Results 4D Molecular Therapeutics Earnings Results Prime Medicine Earnings Results REGENXBIO Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NASDAQ:AUTL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
